Project Grant HT94252310479
Award Date
6/15/23
Completion Date
6/14/27
Dollars Obligated
$1.3M
Federal Agency
Defense Health Agency
Awardee
Purdue University (YRXVL4JYCEF5)
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
West Lafayette, IN, USA
Similar Awards
The Department of the Army Medical Command awarded Purdue University a $2,431,591 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 2022 through September 2026 to study the Role of Comorbid Military-Relevant Stressors in Osteoarthritis. Through this award, Purdue University researchers will investigate the impact of psychological and physiological stress experienced by military service members on the development...
The Department of the Army Medical Command awarded Purdue University a $1,267,673 cooperative agreement under the Military Medical Research and Development program (CFDA 12.420) from September 30, 2021 to September 29, 2025. The award will support research into the long-term consequences of mothers' and fathers' wartime deployments. Purdue will collaborate with the University of California, Los Angeles and the University of Illinois on this research effort. Through the Military Medical...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $144,254.00 to Purdue University to conduct research on "ENDOTHELIAL-TO-MESENCHYMAL TRANSITION IN EPITHELIOID HEMANGIOENDOTHELIOMA." The award period runs from Aug 15, 2024 to Aug 14, 2026. As a prominent research university, Purdue University has extensive experience supporting U.S. government missions through federal contracts and...
Trustees of Indiana University was awarded a $3,953,620 project grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) on May 1, 2023. The grant will fund preclinical testing of a TRPV4 antagonist for the treatment of hydrocephalus in a porcine model through April 30, 2027. Purdue University was issued a subaward as part of the project to use a recently characterized porcine model of post-hemorrhagic hydrocephalus to study hydrocephalic...
Purdue University was awarded a $530,488 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will support research from September 15, 2022 to September 14, 2024 to develop ligand-mediated detection and treatment approaches for metastatic lung cancer, including tumors localized in the central nervous system. Through this funding, Purdue University researchers will investigate medical solutions for...
Purdue University will use a $465,000 Project Grant award from the Department of the Army Medical Command to support research titled "LIGAND-TARGETED MIRNA DELIVERY FOR PROSTATE CANCER THERAPY" from March 2021 to February 2023. The award is funded through the Military Medical Research and Development program (CFDA 12.420), which aims to transform military and public health care through innovative biomedical research solutions for battlefield medicine and other health issues....
This federal Project Grant award from the Defense Health Agency, under the Military Medical Research and Development (CFDA 12.420) program, provides $301,000.00 to the University of Miami to develop an eHealth psychosocial stress and symptom management intervention for patients with pancreatic cancer. The project aims to transform healthcare for military service members and the broader public by investigating innovative approaches to disease prevention, diagnosis, treatment, and management....
The U.S. Defense Health Agency awarded a $1,449,000 Project Grant to Duke University to conduct research aimed at "Identifying Essential Molecular Mechanisms for Advanced Prostate Cancer Growth by a New Chemical Compound." This grant is funded under the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to improve the health and care of military service members, veterans, and their families. The...
The University of Texas Health Science Center at Houston (UTHealth) received a $3,845,822 Project Grant award from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) to conduct a comparative effectiveness study on transdiagnostic behavior therapy versus treatment-as-usual for adjustment disorder following traumatic event exposure. The award runs from July 1, 2024 to June 30, 2028. The federal grant supports innovative biomedical research initiatives aimed at...
This $3,823,679 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports the development and evaluation of a web-based training program for brief cognitive behavioral therapy (BCBT) for suicide prevention. The prime awardee, The Ohio State University, is collaborating with subrecipients The University of Texas Health Science Center at San Antonio, the Medical University of South Carolina, and the University of Memphis...